Diversified Trust Co Acquires 1,516 Shares of Agilent Technologies, Inc. (NYSE:A)

Diversified Trust Co boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 29.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,581 shares of the medical research company’s stock after acquiring an additional 1,516 shares during the quarter. Diversified Trust Co’s holdings in Agilent Technologies were worth $958,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Gibson Capital LLC bought a new position in shares of Agilent Technologies during the 1st quarter worth approximately $188,000. Grimes & Company Inc. lifted its position in shares of Agilent Technologies by 3.1% during the 1st quarter. Grimes & Company Inc. now owns 112,465 shares of the medical research company’s stock worth $16,365,000 after buying an additional 3,392 shares in the last quarter. Occidental Asset Management LLC lifted its position in shares of Agilent Technologies by 0.9% during the 1st quarter. Occidental Asset Management LLC now owns 19,740 shares of the medical research company’s stock worth $2,872,000 after buying an additional 171 shares in the last quarter. S.E.E.D. Planning Group LLC lifted its position in shares of Agilent Technologies by 2.4% during the 1st quarter. S.E.E.D. Planning Group LLC now owns 33,762 shares of the medical research company’s stock worth $4,913,000 after buying an additional 795 shares in the last quarter. Finally, Kathmere Capital Management LLC bought a new position in shares of Agilent Technologies during the 1st quarter worth approximately $243,000. Institutional investors own 87.42% of the company’s stock.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the sale, the chief executive officer now directly owns 25,185 shares in the company, valued at approximately $3,274,050. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the sale, the chief executive officer now owns 25,185 shares in the company, valued at approximately $3,274,050. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Dominique Grau sold 15,000 shares of the stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

Agilent Technologies Price Performance

A opened at $127.46 on Tuesday. The stock has a 50-day moving average price of $139.56 and a 200-day moving average price of $138.50. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $155.35. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of $37.19 billion, a P/E ratio of 30.13, a PEG ratio of 4.40 and a beta of 1.07.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The firm had revenue of $1.57 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.27 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.25 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be issued a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a yield of 0.74%. The ex-dividend date is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio is presently 22.22%.

Analyst Ratings Changes

Several equities analysts have commented on A shares. JPMorgan Chase & Co. dropped their target price on shares of Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. Evercore ISI decreased their price target on shares of Agilent Technologies from $145.00 to $126.00 and set an “in-line” rating for the company in a research note on Thursday, May 30th. Stifel Nicolaus decreased their price target on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a research note on Thursday, May 30th. Bank of America raised their price target on shares of Agilent Technologies from $134.00 to $140.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 25th. Finally, TD Cowen decreased their price target on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating for the company in a research note on Thursday, May 30th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, Agilent Technologies has an average rating of “Hold” and an average price target of $136.88.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.